Financial reports
10-K
2023 FY
Annual report
6 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
ARS
2022 FY
Annual report to shareholders
31 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-QT
Quarterly report for transitional period
30 Mar 22
Current reports
8-K
Other Events
19 Mar 24
8-K
Departure of Directors or Certain Officers
18 Mar 24
8-K
Entry into a Material Definitive Agreement
18 Mar 24
8-K
Other Events
20 Feb 24
8-K
Entry into a Material Definitive Agreement
23 Jan 24
8-K
Departure of Directors or Certain Officers
19 Jan 24
8-K
Other Events
21 Dec 23
8-K
Departure of Directors or Certain Officers
18 Dec 23
8-K
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
26 Sep 23
8-K
Other Events
13 Sep 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
18 Mar 24
S-8
Registration of securities for employees
12 Jul 22
424B5
Prospectus supplement for primary offering
4 Nov 21
424B5
Prospectus supplement for primary offering
1 Sep 21
424B7
Prospectus with selling stockholder info
13 Aug 21
S-3
Shelf registration
15 Jul 21
424B5
Prospectus supplement for primary offering
16 Jun 21
S-3MEF
Registration of additional securities for an S-3
16 Jun 21
S-3
Shelf registration
3 Feb 21
424B5
Prospectus supplement for primary offering
1 Dec 20
Proxies
DEF 14A
Definitive proxy
31 May 23
DEF 14A
Definitive proxy
2 Jun 22
DEF 14A
Definitive proxy
28 Jul 21
PRE 14A
Preliminary proxy
16 Jul 21
DEF 14A
Definitive proxy
30 Jun 20
PRE 14A
Preliminary proxy
16 Jun 20
DEF 14A
Definitive proxy
6 Aug 19
DEF 14A
Definitive proxy
30 Jul 18
DEF 14A
Definitive proxy
1 Aug 17
PRER14A
Preliminary revised proxy
28 Jul 17
Other
EFFECT
Notice of effectiveness
27 Jul 21
CORRESP
Correspondence with SEC
22 Jul 21
UPLOAD
Letter from SEC
21 Jul 21
EFFECT
Notice of effectiveness
11 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
UPLOAD
Letter from SEC
9 Feb 21
CT ORDER
Confidential treatment order
1 May 20
CT ORDER
Confidential treatment order
1 May 20
EFFECT
Notice of effectiveness
11 Feb 20
CORRESP
Correspondence with SEC
6 Feb 20